The objective of the proposed studies is to assess, in older (40-70 years), hypercholesterolemic [low density lipoprotein (LDL) cholesterol 130-160 mg/dl] male subjects, the impact of consuming different sources of protein (mixed-animal versus soy) and/or different levels of isoflavonoids (primarily genestein and diadzein) on the concentration of plasma lipids [total cholesterol, very low density lipoprotein cholesterol, LDL cholesterol, high density lipoprotein cholesterol, triglyceride] and apolipoproteins (apo) [apo A-1, apo B, Lp (a)]; as well as isoflavonoids in plasma and urine; and hormonal status. The experimental design consists of two multi- phased studies devised to determine the independent effects of type of protein and/or level of isoflavonoids; in Study 1, within the context of a diet approximating that currently consumed in the U.S. [15 energy (E) % protein, 47 E% carbohydrate, 38 E% fat (15 E% SFA, 14 E% UFA, 6 E% PUFA), 170 mg cholesterol/1000 kcal] and Study 2, within the context of a diet consistent with recommendations for individuals with moderate hypercholesterolemia (Step 2 diet) [15 E% protein, 49 #% carbohydrate, 24 E% fat (7 E% SFA, 7 E% MUFA, 8 E% PUFA), 61 mg cholesterol/1,000 kcal]. The variable components of the diets, type of protein and isoflavoniods, will respectively comprise two-thirds (67%) of the protein of 10% of energy, and range from 3 to 49 mg/1000 kcal.
The aims of the study are to determine the effect of 1) a one to one (E/E) substitution of soy for mixed-animal protein on plasma lipoprotein, on plasma lipoprotein patterns associated with CHD risk; 3) increasing the isoflavonoid content of the diet in a dose-related manner on plasma lipoprotein patterns associated with CHD risk; 4) dietary protein source on hormonal status (androgens, estrogens, thyroid); and 5) dietary isoflavonoids on hormonal status (androgens, estrogens, thyroid). The area of soy protein and isoflavonoids is highly controversial and in the public domain. The results of these studies, whether positive or negative, should contribute to the data base on which to formulate more specific public health recommendations with respect to decreasing risk of developing CHD.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL058008-03
Application #
6184011
Study Section
Nutrition Study Section (NTN)
Project Start
1998-08-01
Project End
2003-07-31
Budget Start
2000-08-01
Budget End
2001-07-31
Support Year
3
Fiscal Year
2000
Total Cost
$524,477
Indirect Cost
Name
Tufts University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
604483045
City
Boston
State
MA
Country
United States
Zip Code
02111
Vega-López, Sonia; Matthan, Nirupa R; Ausman, Lynne M et al. (2010) Altering dietary lysine:arginine ratio has little effect on cardiovascular risk factors and vascular reactivity in moderately hypercholesterolemic adults. Atherosclerosis 210:555-62
Matthan, Nirupa R; Jalbert, Susan M; Ausman, Lynne M et al. (2007) Effect of soy protein from differently processed products on cardiovascular disease risk factors and vascular endothelial function in hypercholesterolemic subjects. Am J Clin Nutr 85:960-6
Goldin, Barry R; Brauner, Edgard; Adlercreutz, Herman et al. (2005) Hormonal response to diets high in soy or animal protein without and with isoflavones in moderately hypercholesterolemic subjects. Nutr Cancer 51:1-6
Vega-Lopez, Sonia; Yeum, Kyung-Jin; Lecker, Jaime L et al. (2005) Plasma antioxidant capacity in response to diets high in soy or animal protein with or without isoflavones. Am J Clin Nutr 81:43-9
Gordon, Leslie B; Harten, Ingrid A; Patti, Mary Elizabeth et al. (2005) Reduced adiponectin and HDL cholesterol without elevated C-reactive protein: clues to the biology of premature atherosclerosis in Hutchinson-Gilford Progeria Syndrome. J Pediatr 146:336-41
Desroches, Sophie; Mauger, Jean-Francois; Ausman, Lynne M et al. (2004) Soy protein favorably affects LDL size independently of isoflavones in hypercholesterolemic men and women. J Nutr 134:574-9
Lichtenstein, Alice H; Jalbert, Susan M; Adlercreutz, Herman et al. (2002) Lipoprotein response to diets high in soy or animal protein with and without isoflavones in moderately hypercholesterolemic subjects. Arterioscler Thromb Vasc Biol 22:1852-8
Lichtenstein, A H (1998) Soy protein, isoflavones and cardiovascular disease risk. J Nutr 128:1589-92